Literature DB >> 9243048

Pyomyositis of the anterior tibial compartment.

L A Cone1, R B Lamb, A Graff-Radford, J Rudder, S A Bach, J A Hirschberg, J F Feller, R A Lynch.   

Abstract

Five oncology patients developed bacterial pyomyositis involving the anterior tibial compartment and resulting in compartment syndrome with ischemia and abnormalities of neuromuscular function. All patients were neutropenic and thrombocytopenic, and four were receiving or had recently received cancer chemotherapy. Three infections were due to gram-negative bacilli and two to Staphylococcus aureus. Appropriate antimicrobial therapy and surgical drainage in four patients resulted in the resolution of these infections with good residual muscle function. To our knowledge, primary pyomyositis has never previously been known to cause compartment syndrome.

Entities:  

Mesh:

Year:  1997        PMID: 9243048     DOI: 10.1086/514497

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  Escherichia coli pyomyositis in an immunocompromised host.

Authors:  Umesh Sharma; William R Schwan; William A Agger
Journal:  WMJ       Date:  2011-08

Review 2.  Rheumatoid myositis leading to acute lower extremity compartment syndrome: a case-based review.

Authors:  Daniel Jo; Tiffany Pompa; Ambreen Khalil; Frank Kong; Robert Wetz; Mark Goldstein
Journal:  Clin Rheumatol       Date:  2014-05-09       Impact factor: 2.980

Review 3.  Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis.

Authors:  M Gousseff; F Lanternier; A Ferroni; O Chandesris; N Mahlaoui; O Hermine; O Lortholary; M Lecuit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

Review 4.  Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review.

Authors:  Georgios Kalambokis; Areti Theodorou; Paraskevi Kosta; Epameinondas V Tsianos
Journal:  Int J Hematol       Date:  2008-05-21       Impact factor: 2.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.